Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (66)
Coated pits, coated vesicles, and receptor-mediated endocytosis
1979 • 2,073 citations
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
1988 • 1,698 citations
Autocrine growth factors and cancer
1985 • 1,462 citations
Molecular cloning and expression of an IL-6 signal transducer, gp130
1990 • 1,307 citations
Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) Receptor
1988 • 1,063 citations
Association and Activation of Jak-Tyk Kinases by CNTF-LIF-OSM-IL-6 β Receptor Components
1994 • 972 citations
A protein tyrosine kinase in the interferon αβ signaling pathway
1992 • 876 citations
Association of Transcription Factor APRF and Protein Kinase Jak1 with the Interleukin-6 Signal Transducer gp130
1994 • 822 citations
Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6
1989 • 775 citations
The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction
1993 • 766 citations
The soluble interleukin‐6 receptor is generated by shedding
1993 • 502 citations
Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.
1989 • 501 citations
Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
1991 • 419 citations
The Treatment of Multiple Myeloma
1994 • 409 citations
Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient.
1970 • 375 citations
Plasma cell myeloma--new biological insights and advances in therapy
1989 • 299 citations
Plasma cell myeloma--new biological insights and advances in therapy
1989 • 263 citations
Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.
1993 • 233 citations
Response patterns of purified myeloma cells to hematopoietic growth factors
1989 • 231 citations
Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130.
1992 • 206 citations
Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies.
1989 • 179 citations
Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266
1991 • 177 citations
Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma.
1989 • 163 citations
Interleukin 6 gene expression in normal and neoplastic B cells.
1989 • 153 citations
Interleukin-6 is a prognostic factor in multiple myeloma [letter] [see comments]
1991 • 145 citations
Identification of immature and mature myeloma cells in the bone marrow of human myelomas
1993 • 145 citations
Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma
1989 • 141 citations
Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells
1993 • 141 citations
Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxyl-terminal deletion mutants.
1990 • 138 citations
Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.
1994 • 131 citations
Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes.
1989 • 129 citations
Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia
1989 • 126 citations
Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells [see comments]
1990 • 125 citations
Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.
1991 • 123 citations
Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors.
1991 • 118 citations
COOH-Terminal-Modified Interleukin-3 Is Retained Intracellularly and Stimulates Autocrine Growth
1989 • 117 citations
IFN-alpha induces autocrine production of IL-6 in myeloma cell lines.
1991 • 105 citations
Anti‐human interleukin‐6 receptor antibody inhibits human myeloma growth in vivo
1992 • 99 citations
In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma
1991 • 91 citations
gamma-Interferon in multiple myeloma: inhibition of interleukin-6 (IL- 6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro
1993 • 83 citations
IL-2 dependence of the promotion of human B cell differentiation by IL-6 (BSF-2).
1990 • 80 citations
Effects of interferon alpha on autocrine growth factor loops in B lymphoproliferative disorders.
1990 • 76 citations
Autocrine growth factors and tumourigenic transformation
1990 • 75 citations
Phenotypic analysis of human myeloma cell lines
1989 • 74 citations
Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6
1989 • 66 citations
Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression.
1991 • 65 citations
Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression
1991 • 54 citations
Dynamics of interleukin-6 internalization and degradation in rat hepatocytes.
1992 • 52 citations
Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines.
1991 • 48 citations
Differential regulation of interleukin-6 receptor and gp130 gene expression in rat hepatocytes.
1992 • 47 citations
Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop.
1992 • 46 citations
Recombinant interferon‐ γ inhibits the growth of IL‐6‐dependent human multiple myeloma cell lines in vitro
1991 • 46 citations
Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
1991 • 40 citations
A Functional Protein Kinase C Is Required for Induction of 2-5A Synthetase by Recombinant Interferon-αA in Daudi Cells
1989 • 32 citations
The effect of α and γ‐interferon on proliferation and production of IgE and β2‐microglobulin in the human myeloma cell line U‐266 and in an α‐interferon resistant U‐266 subline
1986 • 26 citations
Differential regulation of interleukin‐6 receptors by interleukin‐6 and interferons in multiple myeloma cell lines
1994 • 22 citations
Modulation of Interferon-α and Interferon-γ Receptor Expression during T-Lymphocyte Activation and Proliferation
1986 • 22 citations
The Role of Interferon-α in the Management of Myelomatosis
1992 • 22 citations
Acquisition of growth autonomy and tumorigenicity by an interleukin 6-dependent human myeloma cell line transfected with interleukin 6 cDNA.
1992 • 21 citations
Response patterns of purified myeloma cells to hematopoietic growth factors
1989 • 19 citations
Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia
1989 • 16 citations
Differential expression and ligand-induced modulation of the human interleukin-6 receptor on interleukin-6-responsive cells.
1994 • 16 citations
Identification of immature and mature myeloma cells in the bone marrow of human myelomas
1993 • 15 citations
Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells
1993 • 8 citations
The IL-6 gene but not the IL-6 receptor gene is occasionally rearranged in patients with multiple myeloma.
1990 • 8 citations
Phenotypic analysis of human myeloma cell lines
1989 • 7 citations